diclofenac has been researched along with amoxicillin-potassium clavulanate combination in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Pillans, PI | 1 |
Aguado, L; Ariño, P; Baltasar, M; Cortada, V; Puig, MM | 1 |
Lemaire, V; Lioté, F; Vermeulen, C | 1 |
Daly, AK; Day, CP | 1 |
Kaniwa, N; Saito, Y | 1 |
Aklillu, E; Makonnen, E; Petros, Z | 1 |
Abdallah, A; Abdelsameea, E; Alhaddad, O; Ehsan, N; Elrefaey, A; Elsabaawy, D; Elsabaawy, M; Salama, M; Shabaan, A | 1 |
2 review(s) available for diclofenac and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Genetic association studies in drug-induced liver injury.
Topics: Adverse Drug Reaction Reporting Systems; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Arylamine N-Acetyltransferase; Chemical and Drug Induced Liver Injury; Diclofenac; Floxacillin; Genetic Association Studies; Genetic Predisposition to Disease; HLA-B Antigens; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Phenotype; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors | 2009 |
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Topics: Alleles; Allopurinol; Amoxicillin-Potassium Clavulanate Combination; Azetidines; Benzylamines; Carbamazepine; Chemical and Drug Induced Liver Injury; Diclofenac; Dideoxynucleosides; Drug Hypersensitivity; Floxacillin; Genetic Markers; HLA Antigens; HLA-A Antigens; HLA-B Antigens; HLA-DQ alpha-Chains; Humans; Lapatinib; Pharmacogenetics; Quinazolines; Skin; Stevens-Johnson Syndrome; Ticlopidine | 2013 |
5 other study(ies) available for diclofenac and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Drug associated hepatic reactions in New Zealand: 21 years experience.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anesthetics, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Channel Blockers; Cardiovascular Agents; Cause of Death; Clavulanic Acids; Diclofenac; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Floxacillin; Halothane; Humans; Liver; Male; Middle Aged; New Zealand; Penicillins; Perhexiline; Steroids | 1996 |
Cold urticaria associated with intraoperative hypotension and facial edema.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anesthetics, General; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Atracurium; Atropine; Diclofenac; Down Syndrome; Drug Therapy, Combination; Face; Fentanyl; Hip; Humans; Hypotension; Intraoperative Complications; Legg-Calve-Perthes Disease; Male; Midazolam; Thiopental | 1999 |
[Joint manifestations related to Clostridium difficile].
Topics: Adult; Aged; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Reactive; Clostridioides difficile; Diclofenac; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Feces; Female; Follow-Up Studies; Humans; Ketoprofen; Male; Metronidazole; Middle Aged; Recurrence; Time Factors | 2000 |
Genome-Wide Association Studies for Idiosyncratic Drug-Induced Hepatotoxicity: Looking Back-Looking Forward to Next-Generation Innovation.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cell Adhesion Molecules; Chemical and Drug Induced Liver Injury; Diclofenac; Floxacillin; Genome-Wide Association Study; Genotype; HLA-B Antigens; HLA-DQ beta-Chains; HLA-DRB1 Chains; Humans; Lapatinib; Liver; Proteins; Quinazolines | 2017 |
Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Cyclooxygenase Inhibitors; Diclofenac; Egypt; Female; Hepatic Encephalopathy; Humans; Liver; Liver Failure, Acute; Male; Middle Aged; Prognosis; Prospective Studies; Tertiary Care Centers | 2020 |